# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Sep 15, 2022

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2022-09-15
- Accepted by EDGAR: Sep 15, 2022, 12:07 ET
- Period: 2022-09-14
- Accession: 0001104659-22-100245
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922100245/tm2225930d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465922100245/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465922100245/tm2225930d1_8k.htm

Filed Sep 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-100245. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.